Assessing Drug Interaction and Pharmacokinetics of Loxoprofen in Mice Treated with CYP3A Modulators
Loxoprofen (LOX) is a non-selective cyclooxygenase inhibitor that is widely used for the treatment of pain and inflammation caused by chronic and transitory conditions. Its alcoholic metabolites are formed by carbonyl reductase (CR) and they consist of trans-LOX, which is active, and cis-LOX, which...
Saved in:
Main Authors: | Sanjita Paudel (Author), Aarajana Shrestha (Author), Piljoung Cho (Author), Riya Shrestha (Author), Younah Kim (Author), Taeho Lee (Author), Ju-Hyun Kim (Author), Tae Cheon Jeong (Author), Eung-Seok Lee (Author), Sangkyu Lee (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2019-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring the Metabolism of Loxoprofen in Liver Microsomes: The Role of Cytochrome P450 and UDP-Glucuronosyltransferase in Its Biotransformation
by: Riya Shrestha, et al.
Published: (2018) -
Characterization of CYPs and UGTs Involved in Human Liver Microsomal Metabolism of Osthenol
by: Pil Joung Cho, et al.
Published: (2018) -
Pharmacokinetics of loxoprofen in a self-administered overdose in a Japanese patient admitted to hospital
by: Koichiro Adachi, et al.
Published: (2021) -
Variables Affecting In-Vitro Evaluation of Loxoprofen Sodium Topical Emulgel
by: Zainab H. Mahdi, et al.
Published: (2024) -
Hydrophobic binding peptide-conjugated hybrid lipid-mesoporous silica nanoparticles for effective chemo-photothermal therapy of pancreatic cancer
by: Raj Kumar Thapa, et al.
Published: (2017)